Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness ease pain and protect aging minds?

NCT ID NCT07785648

Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This pilot trial compares an adapted form of mindfulness-based cognitive therapy with a health education program in older Black adults who have chronic pain and early cognitive decline. The goal is to see if the mindfulness approach can improve quality of life and reduce how much pain interferes with daily activities. The study will also check whether participants find the therapy acceptable and credible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness-based cognitive therapy adapted for older adults at risk for chronic pain and early cognitive decline
What this could lead to
If successful, this approach could offer a non-drug way to ease pain's impact on daily life and support mental sharpness in older adults.
What could go wrong
This is a small pilot study, so results may not hold up in larger trials. The therapy requires time and commitment, and benefits may vary from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older adult (age ≥ 50) * All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa * Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months * Early Cognitive Decline (subjective or MCI) * Telephone Interview for Cognitive Status-41 score ≥ 26 * Functional Activities Questionnaire score \< 9 * English fluency/literacy * Ability and willingness to participate via in-person and video * Willing to provide informed consent and comply with all aspects of the protocol Exclusion Criteria: * Current substance abuse/dependence * Significant cognitive impairment * History of more than 8 sessions of cognitive-behavioral therapy * History of previous training in mindfulness or undergoing counseling more than once a month * History of or current diagnosis of psychosis * Active suicidal ideation or self-harm within the past 90 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Mild cognitive impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.